📰 Multicenter Safety Study News
Multicenter Safety Study News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Multicenter Safety Study. Real-time updates on events, politics, business and more.
December 6, 2022
/PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced three presentations on amyotrophic lateral sclerosis (ALS) as part of the Motor...
April 1, 2022
/PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced four presentations on amyotrophic lateral sclerosis (ALS) will be shared as part...
March 11, 2022
/PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that five presentations on amyotrophic lateral sclerosis (ALS) will be shared as...
March 11, 2022
JERSEY CITY, N.J., March 11, 2022 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that five presentations on amyotro...
March 11, 2022
/PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that five presentations on amyotrophic lateral sclerosis (ALS) will be shared as...
March 11, 2022
Press release content from PR Newswire. The AP news staff was not involved in its creation.
March 11, 2022
JERSEY CITY, N.J., March 11, 2022 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that five presentations on amyotro...
October 15, 2021
/PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that two abstracts on amyotrophic lateral sclerosis (ALS) will be presented...
October 6, 2021
/PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that five presentations on amyotrophic lateral sclerosis (ALS) will be shared as...